Feasibility of circulating tumor DNA testing in hepatocellular carcinoma

BACKGROUND: Advancement of technologies enabling clinical assessment of circulating tumor DNA (ctDNA) are allowing for assessment of tumor specific genetic alterations in patients. This holds incredible promise for early detection of disease, serial monitoring of tumor heterogeneity, elucidation of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Gastrointest Oncol
Main Authors: Mody, Kabir, Kasi, Pashtoon Murtaza, Yang, Ju Dong, Surapaneni, Phani Keerthi, Ritter, Ashton, Roberts, Ali, Nagy, Rebecca, Borad, Mitesh J.
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6657310/
https://ncbi.nlm.nih.gov/pubmed/31392055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2019.02.10
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares